{"id":1951,"date":"2025-10-22T10:36:34","date_gmt":"2025-10-22T08:36:34","guid":{"rendered":"https:\/\/okuvision.de\/history\/"},"modified":"2026-05-04T12:02:53","modified_gmt":"2026-05-04T10:02:53","slug":"okuvison-story","status":"publish","type":"page","link":"https:\/\/okuvision.de\/en\/okuvison-story\/","title":{"rendered":"Our Story"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;0&#8243; bottom_padding=&#8221;0&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;126459&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;]\n<div id=\"cvc-hero_image-6a4d641252ef2\" class=\"cvc-element cvc-hero-image cvc-hero-image--violet cvc-hero-image--headline-hl-xl cvc-hero-image--text-large cvc-pattern-top-right-pattern cvc-pattern-bottom-left-pattern\" role=\"region\" aria-label=\"The Okuvision Story\">\n    \n    <!-- Background Patterns -->\n            <div class=\"cvc-hero-image__pattern cvc-hero-image__pattern--left\" aria-hidden=\"true\"><\/div>\n                <div class=\"cvc-hero-image__pattern cvc-hero-image__pattern--right\" aria-hidden=\"true\"><\/div>\n        \n    <!-- Content Container (max-width, centered) -->\n    <div class=\"cvc-hero-image__container\">\n        \n        <div class=\"cvc-hero-image__inner\">\n            <div class=\"cvc-hero-image__content\">\n                \n                                \n                                                        <h1 class=\"cvc-hero-image__headline font-714446 fontsize-431854\">\n                        The Okuvision Story                    <\/h1>\n                                \n                <div class=\"cvc-hero-image__text-wrapper\">\n                                            <div class=\"cvc-hero-image__text-content text-lead\">\n                            <p>From the beginnings to today: how Okuvision co-developed TES therapy, established it in clinical practice, and built care pathways across Europe.<\/p>\n                        <\/div>\n                                        \n                                    <\/div>\n                \n                                \n            <\/div>\n            \n            <!-- Image (breaks out to right edge) -->\n                            <div class=\"cvc-hero-image__image\">\n                    <img width=\"1772\" height=\"997\" src=\"https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw.webp\" class=\"attachment-full size-full\" alt=\"Okuvision Historie \u2013 Glaswand im B\u00fcrogeb\u00e4ude\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw.webp 1772w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw-300x169.webp 300w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw-1024x576.webp 1024w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw-768x432.webp 768w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw-1536x864.webp 1536w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw-350x197.webp 350w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw-uai-720x405.webp 720w, https:\/\/okuvision.de\/wp-content\/uploads\/2025\/12\/OV-Hist_sw-uai-1032x580.webp 1032w\" sizes=\"auto, (max-width: 1772px) 100vw, 1772px\" \/>                <\/div>\n                    <\/div>\n        \n    <\/div>\n    \n<\/div>\n\n\n[\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;2&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;917970&#8243;][vc_column width=&#8221;1\/1&#8243;]\n<div id=\"cvc-anchor-nav-6a4d6412534ce\" class=\"cvc-element cvc-anchor-navigation cvc-anchor-navigation--violet\">\n    <div class=\"cvc-anchor-navigation__container\">\n        <nav class=\"cvc-anchor-navigation__nav\" \n             role=\"navigation\" \n             aria-label=\"Anchor navigation\">\n            \n            <ul class=\"cvc-anchor-navigation__list\">\n                                                        <li class=\"cvc-anchor-navigation__item\">\n                        <a href=\"#gruendung\" \n                           id=\"cvc-anchor-nav-6a4d6412534ce-link-1\"\n                           class=\"cvc-anchor-navigation__link cvc-anchor-navigation__link--active\"\n                           data-smooth-scroll\n                           aria-current=\"location\">\n                            <span class=\"cvc-anchor-navigation__label\">Founding<\/span>\n                                                            <span class=\"cvc-sr-only\">(current section)<\/span>\n                                                    <\/a>\n                    <\/li>\n                                                        <li class=\"cvc-anchor-navigation__item\">\n                        <a href=\"#meilensteine\" \n                           id=\"cvc-anchor-nav-6a4d6412534ce-link-2\"\n                           class=\"cvc-anchor-navigation__link\"\n                           data-smooth-scroll\n                           >\n                            <span class=\"cvc-anchor-navigation__label\">Milestones<\/span>\n                                                    <\/a>\n                    <\/li>\n                                                        <li class=\"cvc-anchor-navigation__item\">\n                        <a href=\"#evidenz\" \n                           id=\"cvc-anchor-nav-6a4d6412534ce-link-3\"\n                           class=\"cvc-anchor-navigation__link\"\n                           data-smooth-scroll\n                           >\n                            <span class=\"cvc-anchor-navigation__label\">Evidence<\/span>\n                                                    <\/a>\n                    <\/li>\n                                                        <li class=\"cvc-anchor-navigation__item\">\n                        <a href=\"#zukunft\" \n                           id=\"cvc-anchor-nav-6a4d6412534ce-link-4\"\n                           class=\"cvc-anchor-navigation__link\"\n                           data-smooth-scroll\n                           >\n                            <span class=\"cvc-anchor-navigation__label\">Future<\/span>\n                                                    <\/a>\n                    <\/li>\n                            <\/ul>\n        <\/nav>\n    <\/div>\n<\/div>\n[\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;172430&#8243; row_name=&#8221;gruendung&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;278904&#8243;]From Idea to Foundation[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;542260&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;163215&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text uncode_shortcode_id=&#8221;202943&#8243;]Okuvision GmbH was established to provide individuals with degenerative retinal diseases (including RP) a treatment option based on the latest advancements in technology and research \u2013 with the clear goal: \u201cPreserving Vision.\u201d<br \/>\nAt the end of 2007, Okuvision was founded as a subsidiary of Retina Implant AG and is now an independent company; its headquarters are in Kusterdingen in the T\u00fcbingen\/Reutlingen Technology Park (TTR). Retinal electrical stimulation (TES) was developed together with experts from the Department of Ophthalmology at T\u00fcbingen University Hospital. <\/p>\n<p>Why this approach? Because it is non-invasive, can be integrated into everyday life, and is carried out under medical supervision. From the outset, the key question was how to combine safety, efficacy, and user-friendliness in a system that can be used at home. Prototypes, user workshops, and feedback from clinics paved the way to the first production-ready system.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;158113&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;meilensteine&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;177493&#8243;]Technological Milestones[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;542260&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;163215&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text uncode_shortcode_id=&#8221;796819&#8243;]At the heart of this is the OkuStim\u00ae system, whose components are continuously being further developed. New scientific findings are incorporated on an ongoing basis; at the same time, Okuvision maintains close dialogue with patients, opticians, and ophthalmologists to strengthen the benefits and everyday usability of the therapy. <\/p>\n<p>For us, technology is not an end in itself: key guiding principles are ease of use, clear feedback during the session (visual\/acoustic), and standardized procedures for weekly use. Equally important: robust materials, transparent maintenance, and consumer-friendly supply of accessories\u2014so that the therapy remains predictable, affordable, and safe.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;154455&#8243; row_name=&#8221;evidenz&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;418423&#8243;]Clinical Evidence and<br \/>\nRegulatory Approval Steps[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;542260&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; medium_width=&#8221;0&#8243; mobile_visibility=&#8221;yes&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;163215&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_column_text uncode_shortcode_id=&#8221;187717&#8243;]Since 2011, several studies involving RP patients have demonstrated the safety and efficacy of electrical stimulation; follow-up studies confirmed the results. OkuStim\u00ae therapy is approved and available as an externally applied therapy for RP based on clinical studies.<br \/>\nFor product approval, Okuvision operates a certified quality management system (QMS); the CE mark as a Class IIa medical device was first granted in 2014. <\/p>\n<p>Why does it take so much effort? Degenerative retinal diseases progress slowly and vary from person to person. Efficacy can therefore only be demonstrated using suitable endpoints and over longer periods of time\u2014e.g., in visual field progression or in patient-relevant outcome measures. In parallel, Good Clinical Practice standards, risk management, and usability tests safeguard care provision.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;0&#8243; bottom_padding=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;353567&#8243; row_name=&#8221;Zukunft&#8221;][vc_column width=&#8221;1\/1&#8243;]\n<div id=\"cvc-cta-6a4d6412535ad\" class=\"cvc-element cvc-cta cvc-cta--headline-hl-xl cvc-cta--text-regular cvc-cta--without-image\" role=\"region\" aria-label=\"Today and Tomorrow: Expanding Care, Advancing Research\">\n    \n    <!-- Image Area with Pattern (only for \"Mit Bild\" variant with actual image) -->\n        \n    <!-- Dark Background Content Area (SINGLE BLOCK for both variants) -->\n    <div class=\"cvc-cta__dark-wrapper style-color-jevc-bg\">\n        \n        <!-- Pattern Top Right - nur f\u00fcr \"Ohne Bild\" Variante -->\n                    <div class=\"cvc-cta__pattern cvc-cta__pattern--top-right\" aria-hidden=\"true\"><\/div>\n                \n        <!-- Pattern Bottom Left - f\u00fcr beide Varianten -->\n        <div class=\"cvc-cta__pattern cvc-cta__pattern--bottom-left\" aria-hidden=\"true\"><\/div>\n        \n        <!-- Content Container (max-width 1200px, centered) -->\n        <div class=\"cvc-cta__container\">\n            <div class=\"cvc-cta__content style-dark\">\n                \n                                    <h2 class=\"cvc-cta__headline text-color-233806-color font-714446 fontsize-431854\">\n                        Today and Tomorrow: Expanding Care, Advancing Research                    <\/h2>\n                                \n                <div class=\"cvc-cta__text-wrapper\">\n                                            <div class=\"cvc-cta__text uncode_text_column\">\n                            <p>Okuvision supplies patients in many European countries with the OkuStim\u00ae system and continuously expands its network of qualified ophthalmologists, centers of excellence, and opticians. The work is guided by evidence, quality, and service\u2014with reliable processes for inquiries from patients, physicians, and care partners. <\/p>\n<p>What does that mean in practice?<\/p>\n<ul>\n<li>Better support: curated information for those affected and their families\u2014from diagnosis to training<\/li>\n<li>Safe use: training by specialist staff, individualized parameters, and regular check-ups<\/li>\n<li>Stay connected: exchange with patient organizations, clinics, and providers to strengthen care regionally and across borders<\/li>\n<li>Think ahead: collaboration with research partners on mechanisms, dosing questions, and care models so that the therapy has a sustainable impact in everyday life<\/li>\n<\/ul>\n<p>\n                        <\/div>\n                                        \n                                            <div class=\"cvc-cta__buttons\" role=\"group\" aria-label=\"Aktionen\">\n                                                        \n                                                            <a href=\"\/en\/quality-policy\/\" \n                                   class=\"oku-button oku-button-md oku-button-white cvc-cta__button cvc-cta__button--secondary\"\n                                                                                                         aria-label=\"Learn More\">\n                                    <span>Learn More<\/span>\n                                    <i class=\"fa fa-arrow-right2\" aria-hidden=\"true\"><\/i>\n                                <\/a>\n                                                    <\/div>\n                                    <\/div>\n                \n            <\/div>\n        <\/div>\n        \n    <\/div>\n    \n<\/div>\n[\/vc_column][\/vc_row][vc_section overlay_alpha=&#8221;50&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;202853&#8243;][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;2&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;230974&#8243; row_name=&#8221;Zeitstrahl&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;107075&#8243;][vc_custom_heading text_size=&#8221;fontsize-431854&#8243; text_weight=&#8221;200&#8243; uncode_shortcode_id=&#8221;253503&#8243;]Milestones of<br \/>\nOkuvision[\/vc_custom_heading][vc_column_text text_lead=&#8221;yes&#8221; uncode_shortcode_id=&#8221;625304&#8243;]Okuvision has already been on a journey. Below you will find an overview.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; inverted_device_order=&#8221;yes&#8221; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;106113&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_right&#8221; gutter_size=&#8221;2&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; align_medium=&#8221;align_left_tablet&#8221; medium_width=&#8221;0&#8243; align_mobile=&#8221;align_left_mobile&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;215828&#8243;][vc_custom_heading text_color=&#8221;color-942029&#8243; heading_semantic=&#8221;p&#8221; text_size=&#8221;fontsize-130582&#8243; text_weight=&#8221;700&#8243; uncode_shortcode_id=&#8221;104359&#8243; el_class=&#8221;text-stroke&#8221; text_color_type=&#8221;uncode-palette&#8221;]2007[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;595703&#8243;]End of 2007 \u2013 Founded (subsidiary of Retina Implant AG) \u2013 now an independent company; headquarters: Kusterdingen.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;248802&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;2&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;144521&#8243;][vc_custom_heading text_color=&#8221;color-942029&#8243; heading_semantic=&#8221;p&#8221; text_size=&#8221;fontsize-130582&#8243; text_weight=&#8221;700&#8243; uncode_shortcode_id=&#8221;906851&#8243; el_class=&#8221;text-stroke&#8221; text_color_type=&#8221;uncode-palette&#8221;]2011[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;127285&#8243;]From 2011 \u2013 Clinical studies with RP patients demonstrate efficacy &amp; safety; further studies follow.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;248802&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;2&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;144521&#8243;][vc_custom_heading text_color=&#8221;color-942029&#8243; heading_semantic=&#8221;p&#8221; text_size=&#8221;fontsize-130582&#8243; text_weight=&#8221;700&#8243; uncode_shortcode_id=&#8221;913169&#8243; el_class=&#8221;text-stroke&#8221; text_color_type=&#8221;uncode-palette&#8221;]2014[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;144437&#8243;]2014 \u2013 CE mark (Class IIa) for the OkuStim\u00ae system within a certified QMS.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;4&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;125134&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;177395&#8243;][vc_custom_heading text_color=&#8221;color-942029&#8243; heading_semantic=&#8221;p&#8221; text_size=&#8221;fontsize-130582&#8243; text_weight=&#8221;700&#8243; uncode_shortcode_id=&#8221;227215&#8243; el_class=&#8221;text-stroke&#8221; text_color_type=&#8221;uncode-palette&#8221;]2025[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;617950&#8243;]2025 \u2013 Approval of OkuStim\u00ae 2.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; equal_height=&#8221;yes&#8221; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; inverted_device_order=&#8221;yes&#8221; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;710610&#8243;][vc_column column_width_percent=&#8221;100&#8243; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_right&#8221; gutter_size=&#8221;2&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; align_medium=&#8221;align_left_tablet&#8221; medium_width=&#8221;0&#8243; align_mobile=&#8221;align_left_mobile&#8221; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; uncode_shortcode_id=&#8221;160383&#8243;][vc_custom_heading text_color=&#8221;color-942029&#8243; heading_semantic=&#8221;p&#8221; text_size=&#8221;fontsize-130582&#8243; text_weight=&#8221;700&#8243; uncode_shortcode_id=&#8221;116293&#8243; el_class=&#8221;text-stroke&#8221; text_color_type=&#8221;uncode-palette&#8221;]Today[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;183596&#8243;]Today \u2013 Europe-wide care provision via a growing network; continuous further development of the components.[\/vc_column_text][\/vc_column][\/vc_row][\/vc_section][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;118356&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;4&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;152446&#8243;][vc_custom_heading text_font=&#8221;font-714446&#8243; text_size=&#8221;fontsize-914237&#8243; text_weight=&#8221;300&#8243; uncode_shortcode_id=&#8221;109998&#8243;]Insights into Therapy,<br \/>\nResearch &amp; Company[\/vc_custom_heading][vc_row_inner][vc_column_inner width=&#8221;1\/1&#8243;][uncode_index el_id=&#8221;index-974899&#8243; index_type=&#8221;carousel&#8221; loop=&#8221;size:3|order_by:date|post_type:post|categories:109|taxonomy_count:10&#8243; carousel_lg=&#8221;3&#8243; carousel_md=&#8221;2&#8243; carousel_sm=&#8221;1&#8243; thumb_size=&#8221;sixteen-nine&#8221; gutter_size=&#8221;3&#8243; post_items=&#8221;media|featured|onpost|original,date,title|-,text|excerpt|200,category|colorbg|relative|display-icon&#8221; carousel_height=&#8221;equal&#8221; carousel_interval=&#8221;3000&#8243; carousel_navspeed=&#8221;400&#8243; advanced_nav=&#8221;yes&#8221; el_id1=&#8221;index-974899&#8243; stage_padding=&#8221;0&#8243; single_back_color=&#8221;color-942029&#8243; single_overlay_opacity=&#8221;50&#8243; single_padding=&#8221;2&#8243; single_title_dimension=&#8221;h4&#8243; single_border=&#8221;yes&#8221; uncode_shortcode_id=&#8221;110426&#8243;][uncode_carousel_nav padding=&#8221;0&#8243; h_align=&#8221;center&#8221; hide_arrows=&#8221;yes&#8221; dots_style=&#8221;lines&#8221; hide_counter=&#8221;yes&#8221; uncode_shortcode_id=&#8221;207978&#8243; target=&#8221;index-974899&#8243; dot_single_width=&#8221;12&#8243; dot_single_active=&#8221;24&#8243; dot_single_height=&#8221;12&#8243; dot_single_radius=&#8221;999&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;0&#8243; top_padding=&#8221;0&#8243; bottom_padding=&#8221;0&#8243; back_color=&#8221;color-206913&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; content_parallax=&#8221;0&#8243; uncode_shortcode_id=&#8221;126459&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1951","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Okuvision \u2013 Our Story<\/title>\n<meta name=\"description\" content=\"From idea to evidence-based retinal therapy: the story of Okuvision \u2013 a pioneer of TES therapy for RP.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/okuvision.de\/en\/okuvison-story\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Our Story\" \/>\n<meta property=\"og:description\" content=\"From idea to evidence-based retinal therapy: the story of Okuvision \u2013 a pioneer of TES therapy for RP.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/okuvision.de\/en\/okuvison-story\/\" \/>\n<meta property=\"og:site_name\" content=\"Okuvision\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-04T10:02:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"11 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/okuvison-story\\\/\",\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/okuvison-story\\\/\",\"name\":\"Okuvision \u2013 Our Story\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#website\"},\"datePublished\":\"2025-10-22T08:36:34+00:00\",\"dateModified\":\"2026-05-04T10:02:53+00:00\",\"description\":\"From idea to evidence-based retinal therapy: the story of Okuvision \u2013 a pioneer of TES therapy for RP.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/okuvison-story\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/okuvision.de\\\/en\\\/okuvison-story\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/okuvison-story\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Story\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/okuvision.de\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/okuvision.de\\\/en\\\/\",\"name\":\"Okuvision\",\"description\":\"\u2013 Sehen erhalten\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/okuvision.de\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Okuvision \u2013 Our Story","description":"From idea to evidence-based retinal therapy: the story of Okuvision \u2013 a pioneer of TES therapy for RP.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/okuvision.de\/en\/okuvison-story\/","og_locale":"en_US","og_type":"article","og_title":"Our Story","og_description":"From idea to evidence-based retinal therapy: the story of Okuvision \u2013 a pioneer of TES therapy for RP.","og_url":"https:\/\/okuvision.de\/en\/okuvison-story\/","og_site_name":"Okuvision","article_modified_time":"2026-05-04T10:02:53+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"11 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/okuvision.de\/en\/okuvison-story\/","url":"https:\/\/okuvision.de\/en\/okuvison-story\/","name":"Okuvision \u2013 Our Story","isPartOf":{"@id":"https:\/\/okuvision.de\/en\/#website"},"datePublished":"2025-10-22T08:36:34+00:00","dateModified":"2026-05-04T10:02:53+00:00","description":"From idea to evidence-based retinal therapy: the story of Okuvision \u2013 a pioneer of TES therapy for RP.","breadcrumb":{"@id":"https:\/\/okuvision.de\/en\/okuvison-story\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/okuvision.de\/en\/okuvison-story\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/okuvision.de\/en\/okuvison-story\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/okuvision.de\/en\/"},{"@type":"ListItem","position":2,"name":"Our Story"}]},{"@type":"WebSite","@id":"https:\/\/okuvision.de\/en\/#website","url":"https:\/\/okuvision.de\/en\/","name":"Okuvision","description":"\u2013 Sehen erhalten","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/okuvision.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/comments?post=1951"}],"version-history":[{"count":34,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1951\/revisions"}],"predecessor-version":[{"id":2544,"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/pages\/1951\/revisions\/2544"}],"wp:attachment":[{"href":"https:\/\/okuvision.de\/en\/wp-json\/wp\/v2\/media?parent=1951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}